By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Oncology. According to news reporting originating from Coburg, Germany, by NewsRx correspondents, research stated, "There are currently many techniques and devices available for the diagnosis of lung cancer. However, rapid on-site diagnosis is essential for early-stage lung cancer, and in the current work we investigated a new diagnostic illumination nanotechnology."
Our news editors obtained a quote from the research from the University of Wurzburg, "Tissue samples were obtained from lymph nodes, cancerous tissue, and abnormal intrapulmonary lesions at our interventional pulmonary suites. The following diagnostic techniques were used to obtain the samples: endobronchial ultrasound bronchoscopy; flexible bronchoscopy; and rigid bronchoscopy. Flexible and rigid forceps were used because several of the patients were intubated using a rigid bronchoscope. In total, 30 tissue specimens from 30 patients were prepared. CytoViva ® illumination nanotechnology was subsequently applied to each of the biopsy tissue slides. A spectral library was created for adenocarcinoma, epidermal growth factor receptor mutation-positive adenocarcinoma, squamous cell carcinoma, usual interstitial pneumonitis, nonspecific interstitial pneumonitis, typical carcinoid tumor, sarcoidosis, idiopathic pulmonary fibrosis, small cell neuroendocrine carcinoma, thymoma, epithelioid and sarcomatoid mesothelioma, cryptogenic organizing pneumonia, malt cell lymphoma, and Wegener's granulomatosis. The CytoViva software, once it had created a specific spectral library for each entity, was able to identify the same disease again in subsequent paired sets of slides of the same disease."
According to the news editors, the research concluded: "Further evaluation of this technique could make this illumination nanotechnology an efficient rapid on-site diagnostic tool."
For more information on this research see: "One-stop shop" spectral imaging for rapid on-site diagnosis of lung cancer: a future concept in nano-oncology. International Journal of Nanomedicine, 2013;8():4533-4542. International Journal of Nanomedicine can be contacted at: Dove Medical Press Ltd, PO Box 300-008, Albany, Auckland 0752, New Zealand (see also Oncology).
The news editors report that additional information may be obtained by contacting K. Darwiche, University of Wurzburg, Coburg Reg Clin, Dept. of Med 2, Coburg, Germany. Additional authors for this research include P. Zarogoulidis, L. Krauss, F. Oezkan, R.F.H. Walter, R. Werner, D. Theegarten, L. Sakkas, A. Sakkas, W. Hohenforst-Scmidt, K. Zarogoulidis and L. Freitag.
Keywords for this news article include: Coburg, Europe, Germany, Genetics, Oncology, Carcinoma, Lung Cancer, Lung Neoplasms, Nanotechnology, Emerging Technologies
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC